Global Life Sciences
Overview
Recommended Insights
0017
Contacts
Services
Advising on the full scope of regulatory, compliance and enforcement, litigation and transactional matters, we can offer you a holistic legal approach that will smooth your path as you navigate industry changes, technological advances, market demands and policy hurdles.
Regions
From high-profile transactions to regulatory issues and complex litigation, we collaborate across borders and disciplines to help our clients in more than 70 countries face challenges and embrace opportunities.

All Professionals
sort


Capabilities
- Antitrust and Competition
- Capital Markets
- Commercial Litigation and Disputes
- Emerging Companies and Venture Capital
- Environmental, Health, and Safety
- Food, Drug and Medical Device
- Global Arbitration, Trade and Advocacy
- Government Strategies
- Healthcare
- IP Litigation
- M&A
- Privacy and Cybersecurity
- Private Equity
- Product Liability and Mass Torts
- Technology Sector
- Technology and Life Sciences Transactions
Related Resources
Related Blogs
News & Insights
Korea Night @ JPM 2026Wednesday, January 14, 2026Global IR Pitching @ JPM 2026 (Co-hosted by KoreaBIO and Sidley)Tuesday, January 13, 2026Recharge & Recaffeinate with Sidley @ JPMMonday, January 12, 2026 – Tuesday, January 13, 2026Biotech Dealmaking – Regulatory Considerations for the Next Wave of Development-Stage Transactions – Program and Lunch @ JPM 2026Monday, January 12, 2026
Receptions
Seminars
Conferences
Conferences
Impact of U.S. FDA Warning Letters in Europe: Practical Considerations for IndustryJanuary 12, 2026Top 10 FDA Areas We Are Watching For 2026January 12, 2026#DrugPricing: More Average Sales Price Proposals and New Comment PeriodJanuary 6, 2026EU Pharma Package: Sharp New Tools With Limited ProtectionsDecember 18, 2025
Food, Drug, and Medical Device Update
Sidley Updates
Global Life Sciences Update
Global Life Sciences Update
DOJ Announces Renewal of FCA Working GroupOctober 2025False Claims Act Liability: When Do Claims for Health Care Reimbursement 'Result From' Anti-Kickback Statute Violations?September 25, 2025Department of Health and Human Services Office of General Counsel Statement of Organization Suggests Potential Consolidation, Expansion of AuthoritySeptember – October 2025Meeting EU Data, Cybersecurity, and Artificial Intelligence Law Obligations: A Checklist for Swiss Life Sciences CompaniesApril 3, 2025
Pratt’s Government Contracting Law Report
Reuters
The Journal of Federal Agency Action
Publications
Korea Night @ JPM 2026Wednesday, January 14, 2026Global IR Pitching @ JPM 2026 (Co-hosted by KoreaBIO and Sidley)Tuesday, January 13, 2026Recharge & Recaffeinate with Sidley @ JPMMonday, January 12, 2026 – Tuesday, January 13, 2026Biotech Dealmaking – Regulatory Considerations for the Next Wave of Development-Stage Transactions – Program and Lunch @ JPM 2026Monday, January 12, 2026
Receptions
Seminars
Conferences
Conferences
Sidley Represents BioRender in Investment Valuing Company at $900 MillionJanuary 2, 2026Sidley Represents Changchun GeneScience (GenSci) Pharmaceuticals in Its Strategic Licensing Agreement With Yarrow Bioscience for First-in-Class Autoimmune Thyroid Disease TherapyDecember 18, 2025First Chair Trial and Leading Product Liability Lawyer Paul Boehm Joins Sidley as Partner in D.C. to Expand Product Liability and Mass Torts Litigation PracticeDecember 18, 2025Sidley Secures Plan Confirmation in Prospect Medical Holdings' US$2.3 Billion Chapter 11 CaseDecember 17, 2025
Announcements
Announcements
Press Releases
Announcements
Sidley Ranked in Chambers Asia-Pacific 2026December 11, 2025Sidley Ranked in Legal 500 Greater China 2026November 19, 2025Five Sidley Partners Named 2025 “MVPs” by Law360November 12, 2025Six Sidley Lawyers Named San Diego 2025 “Leaders of Influence in Law”October 20, 2025
Accolades
Accolades
Accolades
Accolades
U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 12, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025First Circuit Clarifies Application of Medicare’s “Reasonable and Necessary” Standard in FCA Cases Against Clinical LabsDecember 8, 2025Navigating an Uncertain Market Amidst Cautious Optimism: Steps Biotech Companies Can Take to Hedge Against Financial FluctuationsNovember 18, 2025
GoodLifeSci
GoodLifeSci
Original Source
GoodLifeSci
Sidley Partner Meena Datta on How Direct-to-Patient Platforms Are Changing U.S. HealthcareNovember 5, 2025London HIC Biotech CEOs Talk Strategy in Today's ClimateOctober 28, 2025Torrey Cope Featured on Fierce Biotech's The Top Line Podcast Episode, "Unpacking the FDA Transparency Push on CRLs"October 17, 2025Highlights from Sidley Healthcare Investment ConferenceOctober 7, 2025
Videos
Videos
Fierce Biotech
Videos







































